Sevelamer carbonate markedly reduces levothyroxine absorption

Area of Science:

• Endocrinology
• Nephrology
• Clinical Pharmacology

Background:

• Levothyroxine is a standard treatment for hypothyroidism.
• Patients with chronic renal failure often require phosphate binders like sevelamer carbonate.
• Drug interactions can impact the efficacy of thyroid hormone replacement therapy.

Observation:

• A young woman on dialysis developed severe hypothyroidism (TSH=650 mU/L) despite adequate levothyroxine dosage.
• Her condition persisted despite increased levothyroxine doses.
• Symptoms resolved when sevelamer carbonate administration was separated from levothyroxine intake by at least 4 hours.

Findings:

• Sevelamer carbonate significantly reduced levothyroxine absorption.
• This interaction led to clinically significant hypothyroidism in a previously stable patient.
• Altering the timing of drug administration successfully restored thyroid hormone levels.

Implications:

• Clinicians should consider potential interactions between sevelamer carbonate and levothyroxine in dialysis patients.
• Optimizing drug administration schedules is crucial for managing hypothyroidism in patients with chronic kidney disease.
• This case highlights the importance of medication reconciliation and patient education regarding drug absorption.